Unlisted imported drugs likely to approve medical insurance reimbursement.

Published: 2000-03-21 14:38:00

Updated: 2000-03-21 14:38:00

Medical Insurance Price Examination Commission decided to give a chance for unlisted imported drugs to apply the medical insurance reimbursement price approval in 3 months, allowing the drug supplier to clear out the stocks and at the same time considering a continuous supply of such drugs to the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK